This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 Jan;5(1):14-5.

doi: 10.1038/ncpgasthep0996. Epub 2007 Nov 13.

Should somatostatin or gabexate be given for prophylaxis of pancreatitis in patients undergoing ERCP?

Georgios I Papachristou¹

Affiliations

Affiliation

¹ University of Pittsburgh, University of Pittsburgh Medical Center, PUH, Mezzanine 2, C Wing, 200 Lothrop Street, Pittsburgh, PA 15213, USA. papachristoug@dom.pitt.edu

PMID: 17998925
DOI: 10.1038/ncpgasthep0996

Comment

Should somatostatin or gabexate be given for prophylaxis of pancreatitis in patients undergoing ERCP?

Georgios I Papachristou. Nat Clin Pract Gastroenterol Hepatol. 2008 Jan.

. 2008 Jan;5(1):14-5.

doi: 10.1038/ncpgasthep0996. Epub 2007 Nov 13.

Author

Georgios I Papachristou¹

Affiliation

¹ University of Pittsburgh, University of Pittsburgh Medical Center, PUH, Mezzanine 2, C Wing, 200 Lothrop Street, Pittsburgh, PA 15213, USA. papachristoug@dom.pitt.edu

PMID: 17998925
DOI: 10.1038/ncpgasthep0996

No abstract available

PubMed Disclaimer

Comment on

Prophylactic administration of somatostatin or gabexate does not prevent pancreatitis after ERCP: an updated meta-analysis.
Andriulli A, Leandro G, Federici T, Ippolito A, Forlano R, Iacobellis A, Annese V. Andriulli A, et al. Gastrointest Endosc. 2007 Apr;65(4):624-32. doi: 10.1016/j.gie.2006.10.030. Gastrointest Endosc. 2007. PMID: 17383459

Publication types

Actions